During the past decade, Universität Leipzig - Herzzentrum conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universität Leipzig - Herzzentrum" #1 sponsor was "Cordis Corporation" with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "CardioFocus" with 1 trials sponsored, "Cogentus Pharmaceuticals" with 1 trials sponsored and "European Cardiovascular Research Center" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universität Leipzig - Herzzentrum" #1 collaborator was "Cardiovascular European Research Center (CERC)" with 1 trials as a collaborator and "University of Leipzig" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universität Leipzig - Herzzentrum" are "Coronary Artery Disease" (4 trials), "Myocardial Infarction" (2 trials), "Paroxysmal Atrial Fibrillation" (2 trials), "Abdominal Aortic Aneurysms" (1 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Universität Leipzig - Herzzentrum" in a lesser frequency.

Most popular intervention types in "Universität Leipzig - Herzzentrum" are "Device" (9 trials), "Drug" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "46 hrs Holter ECG recording" (1 trials), "ABSORB scaffold" (1 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials), "CardioFocus EAS-AC" (1 trials) and "Cordis AAA stent graft system "INCRAFT TM"" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universität Leipzig - Herzzentrum" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Universität Leipzig - Herzzentrum". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Universität Leipzig - Herzzentrum, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Universität Leipzig - Herzzentrum, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".